EDISON, N.J., Dec. 4, 2019 /PRNewswire/ -- Hackensack Meridian Health has invested in the clinical-stage biotechnology company Adaptive Phage Therapeutics (APT), as part of the health network\'s successful innovation program, the Bear\'s Den. APT is taking aim at the toughest multi-drug...
For more information, please visit
https://www.prnewswire.com:443/news-rele[...]ovation-program-300968546.html